Trilogy Capital’s Proofpoint, Inc. PFPT Stock Holding History

Trilogy Capital’s Portfolio PFPT Stock Details PFPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-30	Closed	-$3K	–	617
2018 Q3	$3K	Hold	30	–	–	﹤0.01%	477
2018 Q2	$3K	Buy	+30	New	+$3.64K	﹤0.01%	438

Other funds holding PFPT

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Trilogy Capital's PFPT Position: Q4 2018 in Review

Trilogy Capital sold out of Proofpoint, Inc. (PFPT) in Q4 2018, closing a stake of 30 shares — an estimated $3K sold.

Trilogy Capital first reported a position in PFPT in Q2 2018 and held it in 2 quarters. The position peaked at $3K in Q3 2018. 298 funds tracked by Wall St. Rank hold PFPT as of Q4 2018.

Trilogy Capital reported no remaining Proofpoint, Inc. position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 30 Proofpoint, Inc. shares in Q4 2018, an estimated $3K.
Trilogy Capital first reported a position in Proofpoint, Inc. in Q2 2018 and held it in 2 quarters.
Trilogy Capital's Proofpoint, Inc. position peaked at $3K in Q3 2018.
298 funds tracked by Wall St. Rank held Proofpoint, Inc. as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.